Fahmueller, Yvonne Nadine <br/><br/>
Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.  [electronic resource] 

 -  International journal of cancer  May 2013 
 - 2349-58 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.27894  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alkaline Phosphatase--blood<br/>Amylases--blood<br/>Analysis of Variance<br/>Antigens, Neoplasm--blood<br/>Apoptosis--immunology<br/>Biomarkers, Tumor--blood<br/>C-Reactive Protein--metabolism<br/>CA-19-9 Antigen--blood<br/>Carcinoembryonic Antigen--blood<br/>Catheter Ablation<br/>Cholinesterases--blood<br/>Colorectal Neoplasms--blood<br/>Deoxyribonucleases--blood<br/>Embolization, Therapeutic--methods<br/>Female<br/>HMGB1 Protein--blood<br/>Humans<br/>Kaplan-Meier Estimate<br/>Keratin-19--blood<br/>L-Lactate Dehydrogenase--blood<br/>Lipase--blood<br/>Liver Neoplasms--blood<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Positron-Emission Tomography<br/>Prognosis<br/>Prospective Studies<br/>Receptor for Advanced Glycation End Products<br/>Receptors, Immunologic--blood<br/>Tomography, X-Ray Computed<br/>Treatment Outcome